conformational change
81Androgen receptor — Structure of the ligand binding domain of the androgen receptor (rainbow cartoon) complexed with testosterone (white sticks).[1] …
82Transketolase — protein Name = transketolase caption = width = HGNCid = 11834 Symbol = TKT AltSymbols = EntrezGene = 7086 OMIM = 606781 RefSeq = NM 001064 UniProt = P29401 PDB = ECnumber = 2.2.1.1 Chromosome = 3 Arm = p Band = 14.3 LocusSupplementaryData =… …
83EcoRV — Eco RV (pronounced eco R five ) is a type II restriction endonuclease isolated from certain strains of Escherichia coli . It has the alternative name Eco32I. In molecular biology, it is a commonly used restriction enzyme. It creates blunt ends.… …
84Light-gated ion channel — Light gated ion channels are a group of transmembrane proteins that form ion channels; pores which open or close in response to light. Most light gated ion channels have been synthesized in the laboratory for study, though one naturally occurring …
85MACPF — Pfam box Symbol = MACPF Name = MAC/Perforin domain width = caption = Pfam= PF01823 InterPro= IPR001862 SMART= MACPF PROSITE = PDOC00251 SCOP = TCDB = 1.C.39 OPM family= OPM protein= PDB=The MACPF protein superfamily is named after a domain that… …
86NCK2 — NCK adaptor protein 2 PDB rendering based on 1u5s …
87NAPA (gene) — N ethylmaleimide sensitive factor attachment protein, alpha Identifiers Symbols NAPA; SNAPA External IDs …
88CAMP dependent pathway — In the field of molecular biology, the cAMP dependent pathway, also known as the adenylyl cyclase pathway, is a G protein coupled receptor triggered signaling cascade used in cell communication.cite book | author = Bruce Alberts, Alexander… …
89AIDS — /aydz/, n. Pathol. a disease of the immune system characterized by increased susceptibility to opportunistic infections, as pneumocystis carinii pneumonia and candidiasis, to certain cancers, as Kaposi s sarcoma, and to neurological disorders:… …
90Cannabinoid receptor antagonist — The discovery of the endogenous cannabinoid system led to the development of CB1 receptor antagonists. The first cannabinoid receptor antagonist, rimonabant, was described in 1994. Rimonabant blocks the CB1 receptor selectively and it has been… …
